NVIDIA Just Made Another Bold AI Bet Across Photonics
NVIDIA backs LUMENTUM and COHERENT with a $4B stake to accelerate AI data movement; analysts weigh the upside and ris...
Why Choose Index Funds Over Active Funds
Why choose index funds over active funds? Because broad diversification, lower costs, and proven long-term results often beat active management.
26,956 articles
Trump Discloses Buys in Boeing and Nvidia Before China Trip
A late-breaking disclosure shows substantial purchases in Boeing and Nvidia by Donald Trump, as markets brace for a h...
These Energy Stocks About to Rally as Driving Season Opens
With summer on the horizon, energy markets react to travel demand and geopolitics. This guide highlights three energy...
Netflix Down From Most High: What History Says for Investors
Netflix is trading well below its latest peak. This article breaks down what the drop means, what history suggests ab...
U.S. Gulf States Have Sought Ukrainian Interceptors for Drones
The U.S. and Gulf states have pressed Kyiv for access to Ukraine’s interceptor tech as Western stocks of high-cost mi...
Lithium Breakthrough Fast-Tracks Global Energy Supply
A startup unveils a proprietary lithium extraction process that dramatically shortens timelines and boosts recovery, ...
Bitcoin Analyst Predicts $200K Within Two Years, Bottom Near
A prominent bitcoin analyst predicts bitcoin could reach $200K within two years, arguing that a near-term bottom is f...
Spacemobile Rocket Lab: Which Stock Is Superior SpaceX Competitor?
Investors chasing SpaceX-style wins without a private bet must weigh public players carefully. This guide compares AS...
Pixelworks (PXLW) 2025 Earnings Outlook and Analysis
Pixelworks' 2025 earnings cycle highlights a niche semiconductor with rising AI-driven display capabilities. This art...
Bicara Stock 50% Jump: A Biotech Bet Hits 29%
A sharp move in bicara stock 50% has spotlighted a bold biotech bet that now accounts for nearly a third of one inves...
Earning $100,000 Your Final Year: Medicare Impact
Retirees face a surprising two-year lag between last-year earnings and Medicare premium changes, even when Social Sec...
Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status